Using low-level red light to control myopia in children
Official title: An Exploratory Study on the Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression
Run by Shanghai Eye Disease Prevention and Treatment Center · NCT06717048 · Data updated 2026-11-12
This study is testing if low-level red light therapy can help slow down worsening eyesight in children aged 8-10 who have mild myopia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years to 10 Years |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | Shanghai Eye Disease Prevention and Treatment Center Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | December 9, 2024 |
| Main results expected | April 9, 2025 |
| Study ends | June 9, 2025 |
| Registry record updated | December 4, 2024 |
| Trial ID | NCT06717048 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 8-10 years with low myopia, specifically those with spherical equivalent refractions ranging from -0.50 to -3.00 diopters.
✕Probably not a fit
Patients with secondary myopia, significant eye diseases, or systemic disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of Repeated Low-level Red-light (RLRL) therapy in controlling myopia progression in children aged 8-10 years with low myopia. The study aims to determine the optimal power and frequency of RLRL exposure and assess the rebound effect after discontinuation of treatment. Conducted as a prospective, double-blind, single-center, randomized controlled trial, it seeks to provide evidence for this innovative approach to myopia prevention and control. The trial addresses a significant public health concern, particularly in East Asia, where myopia is increasingly prevalent.
Why it matters
Potential benefit: If successful, this study could provide a non-invasive method to effectively manage and slow down myopia progression in children.
How similar studies have gone: While the use of RLRL for myopia control is a relatively novel approach, preliminary studies suggest potential effectiveness, warranting further investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age: 8-10 years old 2. Low myopia: cycloplegic spherical equivalent refractions (SERs) range from -0.50 (inclusive) to -3.00 diopters (D) and astigmatism less than -2.5 D in either eye. 3. signed informed consent and was able to participate in the study Exclusion Criteria: 1. Secondary myopia, such as a history of retinopathy of prematurity or other neonatal diseases; syndromic myopia with a known genetic disorder or connective tissue disease, such as Stickler syndrome or Marfan syndrome 2. Strabismus or other binocular vision abnormalities 3. Cloudy refractive media: cloudy cornea, cataract or intraocular lens surgery 4. Eye diseases that affect retinal function: macular degeneration, diabetic retinopathy, retinal detachment, glaucoma or ocular hypertension, endophthalmitis, uveitis, optic neuropathy, etc. 5. History of refractive surgery, internal eye surgery, laser therapy, vitreous injection, etc. 6. diabetes, hypertension and other systemic disorders 7. History of use of retinal toxic drugs, such as hydroxychloroquine, etc. 8. Use of orthokeratology, atropine, multifocal frame glasses and other myopia control methods; children who are currently receiving atropine, orthokeratology, multifocal frame glasses and other myopia control treatment, can be enrolled after 2 weeks of treatment. 9. Other reasons considered unsuitable for inclusion by the study physician, including but not limited to other ocular and systemic disease abnormalities
Where it's running
-
Shanghai Eye Disease Prevention & Treatment Center
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Xiangui He, Prof
- Email: hxgcrco@shsyf.com
- Phone: +862153555032
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
-
Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia
This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.
-
Seeing clearly in low light after Ray-Tracing guided LASIK
A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.